TMZ chemical : Acute Lymphoblastic Leukemia After Temozolomide Treatment for Anaplastic Astrocytoma in a Child With a Germline TP53 Mutation

Resigratinib: A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors